GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HUTCHMED (China) Ltd (FRA:H7T1) » Definitions » Long-Term Capital Lease Obligation

HUTCHMED (China) (FRA:H7T1) Long-Term Capital Lease Obligation : €0.0 Mil (As of Jun. 2024)


View and export this data going back to 2016. Start your Free Trial

What is HUTCHMED (China) Long-Term Capital Lease Obligation?

HUTCHMED (China)'s Long-Term Capital Lease Obligation for the quarter that ended in Jun. 2024 was €0.0 Mil.

HUTCHMED (China)'s quarterly Long-Term Capital Lease Obligation increased from Jun. 2023 (€0.0 Mil) to Dec. 2023 (€2.6 Mil) but then declined from Dec. 2023 (€2.6 Mil) to Jun. 2024 (€0.0 Mil).

HUTCHMED (China)'s annual Long-Term Capital Lease Obligation declined from Dec. 2021 (€6.3 Mil) to Dec. 2022 (€4.9 Mil) and declined from Dec. 2022 (€4.9 Mil) to Dec. 2023 (€2.6 Mil).


HUTCHMED (China) Long-Term Capital Lease Obligation Historical Data

The historical data trend for HUTCHMED (China)'s Long-Term Capital Lease Obligation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HUTCHMED (China) Long-Term Capital Lease Obligation Chart

HUTCHMED (China) Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Long-Term Capital Lease Obligation
Get a 7-Day Free Trial Premium Member Only Premium Member Only 2.74 4.99 6.34 4.91 2.62

HUTCHMED (China) Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Long-Term Capital Lease Obligation Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 4.91 - 2.62 -

HUTCHMED (China)  (FRA:H7T1) Long-Term Capital Lease Obligation Explanation

Long-Term Capital Lease Obligation are the amount due for long-term asset lease agreements that are nearly equivalent to asset purchases. Capital lease obligations are installment payments that constitute a payment of principal plus interest for the capital lease. The Short-Term Capital Lease Obligation is the portion of a Long-Term Capital Lease Obligation that is due over the next year.

Under US Generally Accepted Accounting Principles (GAAP), a capital lease is essentially equivalent to a purchase by the lessee if it meets the following criteria:

1. Ownership of the asset is transferred to the lessee at the end of the lease term;
2. The lease contains a bargain purchase option to buy the equipment at less than fair market value;
3. The lease term equals or exceeds 75% of the asset's estimated useful life;
4. The present value of the lease payments equals or exceeds 90% of the total original cost of the equipment.

HUTCHMED (China) Long-Term Capital Lease Obligation Related Terms

Thank you for viewing the detailed overview of HUTCHMED (China)'s Long-Term Capital Lease Obligation provided by GuruFocus.com. Please click on the following links to see related term pages.


HUTCHMED (China) Business Description

Industry
Address
2 Queen's Road Central, 48th Floor, Cheung Kong Center, Hong Kong, HKG
HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

HUTCHMED (China) Headlines

No Headlines